Ectogenesis—gestation using an artificial womb—is fast approaching reality. Yet without legislation, this innovation also has the potential to cause harm.
“Clinical cases of infections caused by C. auris almost doubled in 2021, according to research published this month in the Annals of Internal Medicine. And the number of cases resistant to echinocandins, the first-line treatment for C. auris infections, tripled. While the fungus generally isn’t a threat for healthy people, it can be dangerous for those with weakened or compromised immune systems, and people using feeding tubes or catheters—in other words, a large proportion of patients in hospitals. The fungus can cause a bloodstream infection whose symptoms include fever, chills, sweats, and low blood pressure. It’s still rare in the U.S., but roughly one in three patients with an invasive infection will die from it; the fungus poses an “urgent threat,” according to the US Centers for Disease Control and Prevention.”
Here’s a scenario that may sound familiar to fans of the postapocalyptic TV drama ‘The Last of Us’: a hard-to-kill fungus is beginning to spread among—and infect—vulnerable populations. Only this time, it’s real.
An Australian team of scientists and engineers invent a tiny, flexible, and soft robotic arm to 3D print biomaterial inside a human body.
The F3DB is a proof-of-concept 3D bioprinter that can be inserted into the body to make repairs to damaged tissue.
♡,♡!!!
In a sense, the extinct woolly mammoth has returned —as a meatball. On Tuesday, an Australian cultured meat start-up revealed a sphere of lab-grown meat, produced with a DNA sequence from the elephant-like mammal.
But you won’t find this product in grocery stores; the creation is not meant to be eaten, at least for now. Instead, the “mammoth meatball” aims to highlight the environmental impacts of standard agricultural practices and present cultured meat as a viable option for food production down the line.
Continue reading “This Massive Meatball Was Made With Woolly Mammoth DNA” »
“Have you heard about Ozempic?” A drug to control blood sugar levels in diabetics is now being touted as a weight-loss panacea.
Ozempic was developed to control blood sugar levels in people with Type 2 Diabetes. A side affect has been significant weight loss.
Previously Fahy has reported as much as a 15 year epigenetic clock reset. Again though, this won’t get you beyond your maximum natural limit, but younger and healthier now leads to the next bridge.
Dr Greg Fahy talks about the thymus magic. What are the out of expectation benefits of reprogramming our thymus(Not TRIIM or TRIIM-X) in this short clip.
Continue reading “A Disease Reversal Therapy That No Body Try Before” »
Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD
Discount Links:
NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
Use Code: ConquerAging At Checkout.
The pursuit of a cure for Alzheimer’s disease is becoming an increasingly competitive and contentious quest with recent years witnessing several important controversies.
In July 2022, Science magazine reported that a key 2006 research paper, published in the prestigious journal Nature, which identified a subtype of brain protein called beta-amyloid as the cause of Alzheimer’s, may have been based on fabricated data.
One year earlier, in June 2021, the US Food and Drug Administration had approved aducanumab, an antibody-targeting beta-amyloid, as a treatment for Alzheimer’s, even though the data supporting its use were incomplete and contradictory.
A research team led by the German Cancer Research Center in Heidelberg, Germany, has discovered that the genetic sequence of a tumor can be read like a molecular clock, traced back to its most recent common ancestor cell. Extracting the duration of tumor evolution can give an accurate predictor of neuroblastoma outcomes.
In a paper published in Nature Genetics titled “Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome,” the team details the steps they took in identifying a genomic clock tested against a whole genome sequenced population combined with analysis and mathematical modeling, to identify evolution markers, traceability and a likely origin point of infant neuroblastomas.
Cancer cells start out life as heroic healthy tissues, with the sort of all for one, one for all, throw yourself on a grenade to save your mates–type attitude that is taking place throughout the body every day. At some point, something goes wrong, and a good cell goes bad.
The use of time-lapse monitoring in IVF does not result in more pregnancies or shorten the time it takes to get pregnant. This new method, which promises to “identify the most viable embryos,” is more expensive than the classic approach. Research from Amsterdam UMC, published today in The Lancet, shows that time-lapse monitoring does not improve clinical results.
Patients undergoing an IVF treatment often have several usable embryos. The laboratory then makes a choice as to which embryo will be transferred into the uterus. Crucial to this decision is the cell division pattern in the first three to five days of embryo development. In order to observe this, embryos must be removed from the incubator daily to be checked under a microscope. In time-lapse incubators, however, built-in cameras record the development of each embryo. This way embryos no longer need to be removed from the stable environment of the incubator and a computer algorithm calculates which embryo has shown the most optimal growth pattern.
More and more IVF centers, across the world, use time-lapse monitoring for the evaluation and selection of embryos. Prospective parents are often promised that time-lapse monitoring will increase their chance of becoming pregnant. Despite frequent use of this relatively expensive method, there are hardly any large clinical studies evaluating the added value of time-lapse monitoring for IVF treatments.
